Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C
- PMID: 2467670
- DOI: 10.1016/0006-291x(89)90028-4
Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C
Abstract
Calphostin C (UCN-1028C), a newly isolated compound from Cladosporium cladosporioides, is a potent and specific inhibitor of protein kinase C, because it was 1000 times more inhibitory to protein kinase C (IC50, 0.05 microM) than other protein kinases such as cAMP-dependent protein kinase and tyrosine-specific protein kinase (IC50, greater than 50 microM). Calphostin C did not inhibit calcium activated neutral protease (calpain)-digested protein kinase C, indicating that it interacts with the regulatory domain of protein kinase C. In addition this compound showed inhibitory effects on the binding of [3H]PDBu to protein kinase C. The potent cytotoxic activity and antitumor activity of calphostin C might be due to the inhibition of protein kinase C, and thus it may be potentially useful for the therapeutic application.
Similar articles
-
Calphostin (UCN1028) and calphostin related compounds, a new class of specific and potent inhibitors of protein kinase C.Adv Second Messenger Phosphoprotein Res. 1990;24:497-501. Adv Second Messenger Phosphoprotein Res. 1990. PMID: 1698411 No abstract available.
-
Potent and specific inhibitors of protein kinase C of microbial origin.Biotechnology (N Y). 1990 Aug;8(8):732-5. doi: 10.1038/nbt0890-732. Biotechnology (N Y). 1990. PMID: 1370017 Review.
-
UCN-1028A, a novel and specific inhibitor of protein kinase C, from Cladosporium.J Antibiot (Tokyo). 1989 Jan;42(1):153-5. doi: 10.7164/antibiotics.42.153. J Antibiot (Tokyo). 1989. PMID: 2466029 No abstract available.
-
Calphostins (UCN-1028), novel and specific inhibitors of protein kinase C. I. Fermentation, isolation, physico-chemical properties and biological activities.J Antibiot (Tokyo). 1989 Oct;42(10):1470-4. doi: 10.7164/antibiotics.42.1470. J Antibiot (Tokyo). 1989. PMID: 2478514
-
Results and speculations related to recent studies on mechanisms of tumor promotion.Carcinog Compr Surv. 1982;7:599-616. Carcinog Compr Surv. 1982. PMID: 7039835 Review. No abstract available.
Cited by
-
Dimerization of matrix metalloproteinase-2 (MMP-2): functional implication in MMP-2 activation.J Biol Chem. 2012 Jun 29;287(27):22643-53. doi: 10.1074/jbc.M111.337949. Epub 2012 May 10. J Biol Chem. 2012. PMID: 22577146 Free PMC article.
-
Protein kinase C pharmacology: refining the toolbox.Biochem J. 2013 Jun 1;452(2):195-209. doi: 10.1042/BJ20130220. Biochem J. 2013. PMID: 23662807 Free PMC article. Review.
-
SARS-CoV-2 Spike Protein Stimulates Macropinocytosis in Murine and Human Macrophages via PKC-NADPH Oxidase Signaling.Antioxidants (Basel). 2024 Jan 30;13(2):175. doi: 10.3390/antiox13020175. Antioxidants (Basel). 2024. PMID: 38397773 Free PMC article.
-
Phorbol ester tumour promoter mediated altered expression and regulation of matrix metalloproteinase-2 in a H-ras transformed cell line capable of benign tumour formation.Mol Cell Biochem. 2001 Apr;220(1-2):39-48. doi: 10.1023/a:1010829117415. Mol Cell Biochem. 2001. PMID: 11451381
-
Protein kinase C-dependent control of Bcl-x alternative splicing.Mol Cell Biol. 2007 Dec;27(24):8431-41. doi: 10.1128/MCB.00565-07. Epub 2007 Oct 8. Mol Cell Biol. 2007. PMID: 17923691 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources